Abstract
Pseudomonas aeruginosa is a dominant pathogen in the airways of cystic fibrosis (CF) 53 patients (Chamber et al. 2005; Lyczak et al. 2002) . The development of a chronic P. aeruginosa 54 pulmonary infection typically correlates with a decline in lung function and mortality in cystic 55 fibrosis (CF) patients (Paganin et al. 2015) . In order to adapt and persist in the CF lung 56 environment, P. aeruginosa alters the expression of metabolic pathways and virulence genes 57 (Bragonzi et al. 2009; Ciofu et al. 2010; Lindsey et al. 2008) , which is largely triggered by stress or 58 nutritional conditions present in the CF lung environment. Some of these phenotypic and genetic 59 modifications include increased antibiotic resistance, the overproduction of the exopolysaccharide 60 alginate, and loss-of-function mutations (Bragonzi et al. 2009; Ciofu et al. 2010 ). The 61 microevolution exhibited by P. aeruginosa CF isolates has proven to be a successful strategy to not 62 only evade the host immune response and avoid clearance from the lung, but to also utilize readily 63 available nutrients present in the host environment.
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Airway sputum supports the growth and nutritional requirements of P. aeruginosa during CF D r a f t D r a f t 5 DNA manipulations, transformations, and conjugations. E. coli strain DH10B was routinely 97 used as a host strain for cloning. DNA was introduced into E. coli by electroporation and into P.
98
aeruginosa by conjugation as previously described (Suh et al. 2004 binding between PAO1, the PAO1 glpR mutant, and complemented strains (Fig. 4) 
